Monday, June 15, 2026

A SKY WRITTEN IN BLOOD : Deciphering The Deadly Trajectory Aimed At Michael DeSombre

North Korea launched unidentified projectiles into the East Sea, marking its first show of force in six weeks, raising regional tensions.

Celebrations Begin: BTS’s Jin Returns, Set to Perform at FESTA 2024

HYBE's stock price began to rise after...

Unsolved Mystery: Naked Man Found Dead in South Korean Sewer

According to local police in Uijeongbu City,...

Tag: precision medicine

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Samsung’s 176 Million USD Investment in Element Biosciences: What It Means for Precision Medicine in Asia

Samsung Electronics invests $176 million in Element Biosciences, enhancing its position in the precision medicine market with advanced genomic technology.

3billion Launches Genome-Based Newborn Screening Service Overseas to Expand Early Genetic Diagnosis

3billion launches 3B-NEO, a genomic newborn screening service to identify genetic disorders in infants, enhancing early diagnosis and treatment.

HLB to Spotlight Liver and Bile Duct Cancer Pipeline at ASCO 2026 With Standalone Global Booth

HLB will showcase liver cancer drug candidates at ASCO 2026, including promising combination therapies and precision medicine studies.

AACR 2026 Highlighted Shift Toward Patient-Centered Cancer Drug Development, Foundation Says

Cancer research is evolving towards patient-centered outcomes, integrating data and technology for better treatments, as noted at AACR 2026.

This New DNA Detection Breakthrough Could Change How Scientists Study Cancer Risk

KRISS and Wright State University developed a precise platform to detect ultra-trace damaged DNA, enhancing cancer research and treatment evaluation.

GC Cell Showcases Cold Chain Innovations the Spring Symposium of the Korean Society of Laboratory Medicine

GC Cell, GC Green Cross, and GC Genome showcased innovations in diagnostics at the 2023 Spring Symposium, enhancing precision medicine.

Penetrium Bioscience Announces Finalization of New Clinical Strategy for Targeted Cancer Therapies

Penetrium Bioscience reveals new clinical strategy to combat drug resistance in cancer therapies at AACR 2026, launching Phase 2 trials.

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

Transforming Healthcare: How Daewoong Pharmaceutical’s Digital Health Strategy Aims for 1 Trillion KRW in 5 Years

Daewoong Pharmaceutical's CEO Lee Chang-jae discusses shifting focus to predictive healthcare and aims for 1 trillion KRW in digital healthcare revenue.

How Keytruda is Revolutionizing Cancer Treatment: Expanded Coverage for Stomach Cancer in 2026

Keytruda's insurance coverage expands to stomach cancer, solidifying its status as a leading universal immunotherapy for various cancers.

3Billion Joins Global iHope Program for Rare Disease Diagnosis: A Game-Changer for Patients in Asia

3Billion becomes the first Asian partner in the iHope program, enhancing rare disease diagnostics for underserved pediatric patients globally.

K-Biohealth Surge: How AI and Precision Medicine are Transforming Global Markets in 2026

South Korean biohealth firms are expanding globally, showcasing AI solutions and forming partnerships at major healthcare events.

How Tumor Microenvironment Stiffness Fuels Cancer Aggressiveness: Key Insights from Pusan National University

A study reveals that tumor microenvironment stiffness increases cancer aggressiveness and treatment resistance, highlighting its significance in treatment strategies.

Breakthrough Tech Tailors Gene Editing to Your DNA

Researchers at Pusan National University developed a tool for personalized gene editing, predicting side effects based on DNA variations.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.